Literature DB >> 18329242

[Management of cancer-related fatigue].

Michel Pavic1, Pascal Sève, Hugues Rousset, Philippe Debourdeau.   

Abstract

INTRODUCTION: Cancer-related fatigue is very common but its management remains frustrating. We thus sought to review current knowledge in this field: epidemiologic data, pathophysiological mechanisms, assessment, and treatment.
METHODS: We queried the Medline database for all articles on this topic published between 1997 and 2007 and analyzed the articles published in English and French, as well as some of the essential earlier work.
RESULTS: Approximately 60 to 96% of patients treated for cancer report fatigue. The prevalence of fatigue that persists after the disease is considered to be in remission is substantial. Fatigue is a multidimensional problem with biological, psychological, social, and personal aspects. Physical causes must be systematically considered (comorbidities, anemia, and endocrine disorders), but most cases remain unresolved. Many may be attributed to deconditioning. There is not now any pharmacological therapy that treats this symptom effectively. Some psychostimulants are being tested, but the initial results of the studies are contradictory. Exercise is the intervention for which there is the most evidence of effectiveness.
CONCLUSION: Cancer-related fatigue is a very common symptom for which no specific cause can usually be identified. In this situation, rest may be more harmful than exercise.

Entities:  

Mesh:

Year:  2008        PMID: 18329242     DOI: 10.1016/j.lpm.2007.09.027

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  Steps toward improving diet and exercise for cancer survivors (STRIDE): a quasi-randomised controlled trial protocol.

Authors:  Lauren J Frensham; Dorota M Zarnowiecki; Gaynor Parfitt; Rebecca M Stanley; James Dollman
Journal:  BMC Cancer       Date:  2014-06-13       Impact factor: 4.430

2.  Evaluation of fatigue in patients with pancreatic cancer receiving chemotherapy treatment: a cross-sectional observational study.

Authors:  Mariacristina Di Marco; Ivan Rubbi; Agnese Baldi; Rosaria Di Lorenzo; Daniela Magnani; Valeria Cremonini; Leopoldo Sarli; Giovanna Artioli; Paola Ferri
Journal:  Acta Biomed       Date:  2018-02-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.